Physician profile
Ashley R Case
NPI 1245448125
$1,739.82
in general payments reported to CMS, 2019-2025
18 companies · $179 in 2025
The $179 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2021: $16.32 · 2022: $389 · 2023: $912 · 2024: $119 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,091 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,091.40 |
| Education | $118.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $342.59 | 2022-2024 | Jemperli, Zejula |
| Myriad Genetic Laboratories, INC. | $242.34 | 2020-2023 | Myrisk |
| Intuitive Surgical, INC. | $241.05 | 2021-2023 | |
| Eisai INC. | $208.60 | 2022-2025 | |
| Astellas Pharma US INC | $143.89 | 2023 | Veozah |
| Astrazeneca Pharmaceuticals LP | $102.71 | 2023-2025 | Lynparza |
| Seagen INC. | $99.99 | 2023 | |
| Merck Sharp & Dohme LLC | $85.48 | 2023-2025 | Keytruda, Lynparza |
| Daiichi Sankyo INC. | $58.34 | 2023-2025 | Enhertu |
| Tactile Systems Technology INC | $41.16 | 2022-2025 | Flexitouch Plus, Nimbl |
| Abbvie INC. | $30.07 | 2025 | |
| Genmab U.S., INC. | $28.97 | 2022-2023 | Tivdak |
| Novartis Pharmaceuticals Corporation | $24.92 | 2025 | |
| Bard Peripheral Vascular, INC. | $21.85 | 2020 | |
| Lilly USA, LLC | $20.15 | 2023 | Retevmo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $16.91 | 2024 | |
| Clovis Oncology, INC. | $15.81 | 2022 | |
| Immunogen, INC. | $14.99 | 2023 | Elahere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.